Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$431M |
| 2 |
Truist Financial
TFC
|
+$346M |
| 3 |
Alibaba
BABA
|
+$238M |
| 4 |
ServiceNow
NOW
|
+$228M |
| 5 |
Corteva
CTVA
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$875M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$395M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$340M |
| 4 |
Oracle
ORCL
|
+$197M |
| 5 |
Apple
AAPL
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 14.48% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
ANI Pharmaceuticals
ANIP
$1.72B
| $7.93M | ﹤0.01% |
128,607
-4,510
| -3% | -$299K |
|
2327
Travere Therapeutics
TVTX
$5.79B
| $7.93M | ﹤0.01% |
558,251
+4,203
| +0.8% | +$53.7K |
|
|
BZUN
2328
Baozun
BZUN
$168M
| $7.92M | ﹤0.01% |
239,181
+7,662
| +3% | +$304K |
|
2329
V2X
VVX
$2.55B
| $7.92M | ﹤0.01% |
154,422
+1,521
| +1% | +$73.3K |
|
|
MMP
2330
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $7.9M | ﹤0.01% |
125,645
-8,607
| -6% | -$536K |
|
|
SRDX
2331
DELISTED
Surmodics
SRDX
| $7.89M | ﹤0.01% |
190,456
-5,540
| -3% | -$233K |
|
2332
The Bancorp
TBBK
$2.82B
| $7.89M | ﹤0.01% |
607,969
-10,688
| -2% | -$120K |
|
2333
Axogen
AXGN
$2.58B
| $7.86M | ﹤0.01% |
439,482
-45,314
| -9% | -$670K |
|
2334
Midland States Bancorp
MSBI
$698M
| $7.86M | ﹤0.01% |
271,501
-4,828
| -2% | -$133K |
|
2335
Unisys
UIS
$210M
| $7.8M | ﹤0.01% |
657,748
-6,053
| -0.9% | -$60.7K |
|
2336
TechTarget
TTGT
$277M
| $7.78M | ﹤0.01% |
298,070
-37,853
| -11% | -$961K |
|
|
WSR
2337
DELISTED
Whitestone REIT
WSR
| $7.75M | ﹤0.01% |
569,336
+1,140
| +0.2% | +$15.7K |
|
2338
Peapack-Gladstone Financial
PGC
$822M
| $7.74M | ﹤0.01% |
250,378
-8,162
| -3% | -$240K |
|
2339
Krystal Biotech
KRYS
$9.72B
| $7.73M | ﹤0.01% |
139,594
-3,455
| -2% | -$169K |
|
|
ADVM
2340
DELISTED
Adverum Biotechnologies
ADVM
| $7.7M | ﹤0.01% |
66,855
+3,339
| +5% | +$294K |
|
2341
Brookfield Infrastructure Partners
BIP
$18.4B
| $7.69M | ﹤0.01% |
258,458
-3,642
| -1% | -$109K |
|
2342
Mercantile Bank Corp
MBWM
$1.06B
| $7.68M | ﹤0.01% |
210,711
-4,605
| -2% | -$162K |
|
2343
Upwork
UPWK
$1.08B
| $7.68M | ﹤0.01% |
719,446
-10,966
| -2% | -$138K |
|
2344
Quanex
NX
$981M
| $7.68M | ﹤0.01% |
449,410
-8,762
| -2% | -$165K |
|
2345
Coca-Cola Femsa
KOF
$22.9B
| $7.67M | ﹤0.01% |
126,564
-30,052
| -19% | -$1.77M |
|
2346
OneSpan
OSPN
$624M
| $7.67M | ﹤0.01% |
448,014
-10,757
| -2% | -$183K |
|
2347
Modine Manufacturing
MOD
$10.8B
| $7.65M | ﹤0.01% |
993,107
-16,953
| -2% | -$152K |
|
|
TSC
2348
DELISTED
TriState Capital Holdings, Inc.
TSC
| $7.64M | ﹤0.01% |
292,519
-6,311
| -2% | -$150K |
|
|
SPTN
2349
DELISTED
SpartanNash
SPTN
| $7.63M | ﹤0.01% |
535,914
-4,914
| -0.9% | -$64.9K |
|
2350
Palomar
PLMR
$3.37B
| $7.6M | ﹤0.01% |
150,605
+73,167
| +94% | +$3.43M |
|
Similar funds
Northern Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
- Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
- Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
- Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
- Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
- Northern Trust opened 134 new positions and closed 124 in Q4 2019.
- Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.
Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.